www.moodys.com/research/Moodys-changes-outlook-on-AstraZenacas-A3-rating-to-negative-affirms--PR_370579

Jul 28, 2017 ... Issuer: Zeneca Wilmington Inc. ....BACKED Senior Unsecured Regular Bond/ Debenture, Affirmed A3. Outlook Actions: ....Outlook, Changed To ...

www.ocutx.com/about/leadership/w-james-oshea

For nearly a decade, Mr. O'Shea held leadership positions at Sepracor, Inc. He ... Medical Affairs for Zeneca Pharmaceuticals, a business unit of Astra Zeneca ...

www.njcourts.gov/attorneys/assets/mcl/rsz/Graves.pdf

(973) 267-0058. Attorneys for Defendants AstraZeneca Pharmaceuticals LP,. AstraZeneca LP, Astra USA, Inc., KBI Sub Inc., and Zeneca Inc. NOEL GRAVES,.

www.genengnews.com/topics/drug-discovery/astrazeneca-to-acquire-zs-pharma-for-2-7b

Nov 6, 2015 ... AstraZeneca said today it will acquire ZS Pharma for approximately $2.7 billion, in a deal designed to expand the buyer's cardiovascular and ...

investor.aveooncology.com/news-releases/news-release-details/aveo-oncology-announces-immuno-oncology-clinical-collaboration

Dec 12, 2018 ... “We are thrilled to collaborate with AstraZeneca to explore another ... About AVEO. AVEO Pharmaceuticals, Inc. (the “Company” or “AVEO”) is a ...

www.scaledagileframework.com/astra-zeneca-case-study

Agile at AstraZeneca: Expediting Time-to-Value Delivery .... Scaled Agile Framework and SAFe are registered trademarks of Scaled Agile, Inc. Please visit  ...

investor.arraybiopharma.com/news-releases/news-release-details/array-biopharma-and-astrazeneca-announce-oncology-collaboration

AstraZeneca acquires exclusive worldwide rights to ARRY-142886 and .... of Array BioPharma Inc., +1-303-386-1193, thaugeto@arraybiopharma.com ; or

www.barrons.com/articles/astrazeneca-sells-10-7-million-in-albireo-stock-1512511373

Dec 5, 2017 ... AstraZeneca sold 500000 shares, halving its stake in the company, an AstraZeneca spinoff.

www.fundinguniverse.com/company-histories/avecia-group-plc-history

Incorporated: 1999 ... 1993: The Biochemicals division is spun off as Zeneca, and includes ICI specialty chemicals operations, renamed as Zeneca Specialties.